Thermo Fisher Scientific Inc. reported earnings results for the third quarter and nine months ended October 01, 2022. For the third quarter, the company reported sales was USD 10,677 million compared to USD 9,330 million a year ago. Net income was USD 1,495 million compared to USD 1,902 million a year ago. Basic earnings per share from continuing operations was USD 3.82 compared to USD 4.83 a year ago. Diluted earnings per share from continuing operations was USD 3.79 compared to USD 4.79 a year ago.
For the nine months, sales was USD 33,465 million compared to USD 28,509 million a year ago. Net income was USD 5,374 million compared to USD 6,067 million a year ago. Basic earnings per share from continuing operations was USD 13.72 compared to USD 15.41 a year ago. Diluted earnings per share from continuing operations was USD 13.62 compared to USD 15.29 a year ago.